PortfoliosLab logoPortfoliosLab logo
REGN vs. NEE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

REGN vs. NEE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Regeneron Pharmaceuticals, Inc. (REGN) and NextEra Energy, Inc. (NEE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, REGN achieves a -18.32% return, which is significantly lower than NEE's 7.45% return. Over the past 10 years, REGN has underperformed NEE with an annualized return of 4.61%, while NEE has yielded a comparatively higher 13.69% annualized return.


REGN

1D
1.58%
1M
-10.34%
YTD
-18.32%
6M
-12.78%
1Y
30.36%
3Y*
-5.46%
5Y*
4.37%
10Y*
4.61%

NEE

1D
1.30%
1M
-11.01%
YTD
7.45%
6M
3.45%
1Y
25.24%
3Y*
8.09%
5Y*
6.04%
10Y*
13.69%
*Multi-year figures are annualized to reflect compound growth (CAGR)

REGN vs. NEE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
REGN
Regeneron Pharmaceuticals, Inc.
-18.32%8.96%-18.90%21.73%14.25%30.72%28.66%0.53%-0.65%2.42%
NEE
NextEra Energy, Inc.
7.45%15.47%21.46%-25.30%-8.54%23.39%30.06%42.69%14.30%34.39%

Correlation

The correlation between REGN and NEE is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (10Y)
Calculated over the trailing 10-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Jan 13, 2003

0.18

Fundamentals

EPS

REGN:

$41.05

NEE:

$5.27

PE Ratio

REGN:

15.32

NEE:

16.26

PS Ratio

REGN:

4.54

NEE:

4.76

Total Revenue (TTM)

REGN:

$14.92B

NEE:

$27.93B

Gross Profit (TTM)

REGN:

$12.61B

NEE:

$13.35B

EBITDA (TTM)

REGN:

$5.74B

NEE:

$14.56B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

REGN vs. NEE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

REGN
REGN Risk / Return Rank: 6767
Overall Rank
REGN Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
REGN Sortino Ratio Rank: 6666
Sortino Ratio Rank
REGN Omega Ratio Rank: 6464
Omega Ratio Rank
REGN Calmar Ratio Rank: 6565
Calmar Ratio Rank
REGN Martin Ratio Rank: 7272
Martin Ratio Rank

NEE
NEE Risk / Return Rank: 7171
Overall Rank
NEE Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
NEE Sortino Ratio Rank: 6868
Sortino Ratio Rank
NEE Omega Ratio Rank: 6767
Omega Ratio Rank
NEE Calmar Ratio Rank: 7272
Calmar Ratio Rank
NEE Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

REGN vs. NEE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and NextEra Energy, Inc. (NEE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


REGNNEEDifference
Sharpe ratioReturn per unit of total volatility

-0.14

Sortino ratioReturn per unit of downside risk

-0.10

Omega ratioGain probability vs. loss probability

1.18

1.21

-0.02

Calmar ratioReturn relative to maximum drawdown

1.18

1.75

-0.57

Martin ratioReturn relative to average drawdown

4.09

5.17

-1.09

REGN vs. NEE - Sharpe Ratio Comparison

The current REGN Sharpe Ratio is 0.93, which is comparable to the NEE Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of REGN and NEE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


REGNNEEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.93

1.07

-0.14

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.14

0.23

-0.08

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.14

0.54

-0.39

Sharpe Ratio (All Time)

Calculated using the full available price history

0.16

0.62

-0.46

Drawdowns

REGN vs. NEE - Drawdown Comparison

The maximum REGN drawdown since its inception was -91.81%, which is greater than NEE's maximum drawdown of -47.81%. Use the drawdown chart below to compare losses from any high point for REGN and NEE.


Loading charts...

Drawdown Indicators


REGNNEEDifference

Max Drawdown

Largest peak-to-trough decline

-91.81%

-47.81%

-44.00%

Max Drawdown (1Y)

Largest decline over 1 year

-25.85%

-14.53%

-11.32%

Max Drawdown (3Y)

Largest decline over 3 years

-59.69%

-34.57%

-25.12%

Max Drawdown (5Y)

Largest decline over 5 years

-59.69%

-44.97%

-14.72%

Max Drawdown (10Y)

Largest decline over 10 years

-59.69%

-44.97%

-14.72%

Current Drawdown

Current decline from peak

-47.25%

-12.46%

-34.79%

Average Drawdown

Average peak-to-trough decline

-42.39%

-8.92%

-33.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.45%

4.89%

+2.56%

Volatility

REGN vs. NEE - Volatility Comparison

Regeneron Pharmaceuticals, Inc. (REGN) has a higher volatility of 12.54% compared to NextEra Energy, Inc. (NEE) at 8.41%. This indicates that REGN's price experiences larger fluctuations and is considered to be riskier than NEE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


REGNNEEDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.54%

8.41%

+4.13%

Volatility (6M)

Calculated over the trailing 6-month period

22.39%

17.08%

+5.31%

Volatility (1Y)

Calculated over the trailing 1-year period

32.85%

23.81%

+9.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

30.77%

26.90%

+3.87%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.16%

25.48%

+6.68%

Dividends

REGN vs. NEE - Dividend Comparison

REGN's dividend yield for the trailing twelve months is around 0.58%, less than NEE's 2.05% yield.


PositionTTM20252024202320222021202020192018201720162015
NEE
NextEra Energy, Inc.
2.05%2.82%2.87%3.08%2.03%1.65%1.81%2.06%2.55%2.52%2.91%2.96%
REGN
Regeneron Pharmaceuticals, Inc.
0.58%0.46%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

REGN vs. NEE - Financials Comparison

This section allows you to compare key financial metrics between Regeneron Pharmaceuticals, Inc. and NextEra Energy, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


3.00B4.00B5.00B6.00B7.00B8.00B20222023202420252026
3.61B
6.70B
(REGN) Total Revenue
(NEE) Total Revenue
Values in USD except per share items

REGN vs. NEE - Profitability Comparison

The chart below illustrates the profitability comparison between Regeneron Pharmaceuticals, Inc. and NextEra Energy, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
81.4%
0
Portfolio components
REGN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported a gross profit of 2.94B and revenue of 3.61B. Therefore, the gross margin over that period was 81.4%.

NEE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, NextEra Energy, Inc. reported a gross profit of 0.00 and revenue of 6.70B. Therefore, the gross margin over that period was 0.0%.

REGN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported an operating income of 642.90M and revenue of 3.61B, resulting in an operating margin of 17.8%.

NEE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, NextEra Energy, Inc. reported an operating income of 2.21B and revenue of 6.70B, resulting in an operating margin of 33.0%.

REGN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported a net income of 727.20M and revenue of 3.61B, resulting in a net margin of 20.2%.

NEE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, NextEra Energy, Inc. reported a net income of 2.18B and revenue of 6.70B, resulting in a net margin of 32.6%.


Frequently Asked Questions


REGN and NEE have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

REGN has higher volatility (12.54%) compared to NEE (8.41%). In terms of maximum drawdown, REGN dropped -91.81% vs NEE's -47.81%.

NEE currently has the higher Sharpe Ratio (1.07 vs 0.93), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for REGN and NEE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer